Cite
Combined Nivolumab and Ipilimumab in Octogenarian and Nonagenarian Melanoma Patients.
MLA
Reichert, Constance, et al. “Combined Nivolumab and Ipilimumab in Octogenarian and Nonagenarian Melanoma Patients.” Cancers, vol. 15, no. 17, Sept. 2023, p. 4330. EBSCOhost, https://doi.org/10.3390/cancers15174330.
APA
Reichert, C., Baldini, C., Mezghani, S., Maubec, E., Longvert, C., Mortier, L., Quereux, G., Jannic, A., Machet, L., de Quatrebarbes, J., Nardin, C., Beneton, N., Amini Adle, M., Funck-Brentano, E., Descamps, V., Hachon, L., Malissen, N., Baroudjian, B., & Brunet-Possenti, F. (2023). Combined Nivolumab and Ipilimumab in Octogenarian and Nonagenarian Melanoma Patients. Cancers, 15(17), 4330. https://doi.org/10.3390/cancers15174330
Chicago
Reichert, Constance, Capucine Baldini, Sarah Mezghani, Eve Maubec, Christine Longvert, Laurent Mortier, Gaëlle Quereux, et al. 2023. “Combined Nivolumab and Ipilimumab in Octogenarian and Nonagenarian Melanoma Patients.” Cancers 15 (17): 4330. doi:10.3390/cancers15174330.